{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:49:14Z","timestamp":1783939754055,"version":"3.55.0"},"reference-count":70,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["BIOT"],"published-print":{"date-parts":[[2019,10,25]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The Human Cytomegalovirus (HCMV) has infected more than 90% of the world population and its prevalence can be related to the individuals geographical and socialeconomic status. Serological tests based on ELISA are pivotal for HCMV diagnosis. Due to the lack of standardization in the production\/purification of antigens from viral preparations, ELISA tests are based on several recombinant proteins or peptides. As an alternative, multiepitope proteins may be employed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>In this work, we developed a recombinant multiepitope protein (rMEHCMV) for HCMV diagnosis based on conserved and immunodominant epitopes derived from tegument (pp150, pp65 and pp28), glycoprotein gB (pp38) and DNA polymerase subunit (pp52) of HCMV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The rMEHCMV gene was synthesized de novo and overexpressed in Escherichia coli cells. The recombinant protein was purified to homogeneity using a Ni-NTA column. Biophysical analysis of recombinant protein was performed by circular dichroism. A preliminary biological activity test was performed using 12 positive human sera samples by using an in-house IgG ELISA. The following patents database were consulted: Espacenet, Google Patents and the National Institute of Intellectual Property (INPI, Brazil).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The recombinant multiepitope protein was successfully expressed in E. coli. The structural data obtained by circular dichroism spectroscopy showed that rMEHCMV is structurally disordered. An in-house IgG ELISA test with rMEHCMV was successfully used to recognized IgG from human serum samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Together, our results show that rMEHCMV should be considered as a potential antigenic target for HCMV diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1872208313666190716093911","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:00:57Z","timestamp":1563872457000},"page":"316-328","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Custom-Designed Recombinant Multiepitope Protein for Human Cytomegalovirus Diagnosis"],"prefix":"10.2174","volume":"13","author":[{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"first","affiliation":[{"name":"Laboratorio de Biotecnologia de Microrganismos, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilen Q.","family":"Souza","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Celular, Universidade de Brasilia, Bras\u00edlia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia de Microrganismos, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C. M.","family":"\u00c1lvares","sequence":"additional","affiliation":[{"name":"Laboratorio de Biofisica, Universidade de Brasilia, Brasilia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds M.","family":"Nogueira","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia de Microrganismos, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"Machado","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia de Microrganismos, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Celular, Universidade de Brasilia, Bras\u00edlia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato R.","family":"Godoi","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia de Microrganismos, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna K.M.","family":"Nobrega","sequence":"additional","affiliation":[{"name":"Laboratorio de Doencas Imunogeneticas e Cronico-degenerativas, Universidade de Brasilia, Brasilia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Campos-da-Paz","sequence":"additional","affiliation":[{"name":"Laboratorio de Nanobiotecnologia, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"de Freitas","sequence":"additional","affiliation":[{"name":"Laboratorio de Biofisica, Universidade de Brasilia, Brasilia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.S.","family":"Felipe","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Celular, Universidade de Brasilia, Bras\u00edlia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.G.","family":"Torres","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Celular, Universidade de Brasilia, Bras\u00edlia, DF, 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexsandro S.","family":"Galdino","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia de Microrganismos, Universidade Federal de Sao Joao Del-Rei, Divinopolis, MG, 35501-296, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","volume":"22","author":"Crough T.","year":"2009","unstructured":"Crough T.; Khanna R.; Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009,22(1),76-98","journal-title":"Clin Microbiol Rev"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0163-7258(03)00034-2","volume":"98","author":"Landolfo S.","year":"2003","unstructured":"Landolfo S.; Gariglio M.; Gribaudo G.; Lembo D.; The human cytomegalovirus. Pharmacol Ther 2003,98(3),269-297","journal-title":"Pharmacol Ther"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","volume":"338","author":"Stern-Ginossar N.","year":"2012","unstructured":"Stern-Ginossar N.; Weisburd B.; Michalski A.; Decoding human cytomegalovirus. Science 2012,338(6110),1088-1093","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.humimm.2004.02.008","volume":"65","author":"Britt W.J.","year":"2004","unstructured":"Britt W.J.; Boppana S.; Human cytomegalovirus virion proteins. Hum Immunol 2004,65(5),395-402","journal-title":"Hum Immunol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2014.00230","volume":"4","author":"Herbein G.","year":"2014","unstructured":"Herbein G.; Kumar A.; The oncogenic potential of human cytomegalovirus and breast cancer. Front Oncol 2014,4,230","journal-title":"Front Oncol"},{"key":"ref=6","first-page":"1","volume":"1","author":"Ahmed A.","year":"2014","unstructured":"Ahmed A.; Immunopathology of CMV co-infection. MOJ Immunol 2014,1,1-6","journal-title":"MOJ Immunol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajo.12408","volume":"56","author":"Naing Z.W.","year":"2016","unstructured":"Naing Z.W.; Scott G.M.; Shand A.; Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. Aust N Z J Obstet Gynaecol 2016,56(1),9-18","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/rmv.695","volume":"21","author":"Cannon M.J.","year":"2011","unstructured":"Cannon M.J.; Hyde T.B.; Schmid D.S.; Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011,21(4),240-255","journal-title":"Rev Med Virol"},{"key":"ref=9","first-page":"343","volume":"89","author":"Luscalov S.","year":"2016","unstructured":"Luscalov S.; Loga L.; Dican L.; Junie L.M.; Cytomegalovirus infection in immunosuppressed patients after kidney transplantation. Clujul Med 2016,89(3),343-346","journal-title":"Clujul Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cll.2016.01.011","volume":"36","author":"Feldman D.M.","year":"2016","unstructured":"Feldman D.M.; Keller R.; Borgida A.F.; Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med 2016,36(2),407-419","journal-title":"Clin Lab Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5500\/wjt.v5.i4.287","volume":"5","author":"Bhat V.","year":"2015","unstructured":"Bhat V.; Joshi A.; Sarode R.; Chavan P.; Cytomegalovirus infection in the bone marrow transplant patient. World J Transplant 2015,5(4),287-291","journal-title":"World J Transplant"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fmicb.2016.00715","volume":"7","author":"Luganini A.","year":"2016","unstructured":"Luganini A.; Terlizzi M.E.; Gribaudo G.; Bioactive molecules released from cells infected with the human cytomegalovirus. Front Microbiol 2016,7,715","journal-title":"Front Microbiol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2055-6640(20)30457-X","volume":"2","author":"McIntosh M.","year":"2016","unstructured":"McIntosh M.; Hauschild B.; Miller V.; Human cytomegalovirus and transplantation: drug development and regulatory issues. J Virus Erad 2016,2(3),143-148","journal-title":"J Virus Erad"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0928-0197(94)90049-3","volume":"2","author":"Weber B.","year":"1994","unstructured":"Weber B.; Prosser F.; Munkwitz A.; Doerr H.W.; Serological diagnosis of cytomegalovirus infection: comparison of 8 enzyme immunoassays for the detection of HCMV-specific IgM antibody. Clin Diagn Virol 1994,2(4-5),245-259","journal-title":"Clin Diagn Virol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0166-0934(01)00325-1","volume":"96","author":"Weber B.","year":"2001","unstructured":"Weber B.; Berger A.; Rabenau H.; Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection. J Virol Methods 2001,96(2),157-170","journal-title":"J Virol Methods"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcv.2008.05.011","volume":"43","author":"Busse C.","year":"2008","unstructured":"Busse C.; Strubel A.; Schnitzler P.; Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies. J Clin Virol 2008,43(2),137-141","journal-title":"J Clin Virol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/315165","volume":"181","author":"Houghton R.L.","year":"2000","unstructured":"Houghton R.L.; Benson D.R.; Reynolds L.; Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas\u2019 disease. J Infect Dis 2000,181(1),325-330","journal-title":"J Infect Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virusres.2005.03.022","volume":"112","author":"Anandarao R.","year":"2005","unstructured":"Anandarao R.; Swaminathan S.; Khanna N.; The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides. Virus Res 2005,112(1-2),60-68","journal-title":"Virus Res"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/CVI.13.1.59-67.2006","volume":"13","author":"Anandarao R.","year":"2006","unstructured":"Anandarao R.; Swaminathan S.; Fernando S.; Jana A.M.; Khanna N.; Recombinant multiepitope protein for early detection of dengue infections. Clin Vaccine Immunol 2006,13(1),59-67","journal-title":"Clin Vaccine Immunol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pep.2005.12.012","volume":"47","author":"Dipti C.A.","year":"2006","unstructured":"Dipti C.A.; Jain S.K.; Navin K.; A novel recombinant multiepitope protein as a hepatitis C diagnostic intermediate of high sensitivity and specificity. Protein Expr Purif 2006,47(1),319-328","journal-title":"Protein Expr Purif"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CVI.00400-09","volume":"17","author":"Duthie M.S.","year":"2010","unstructured":"Duthie M.S.; Hay M.N.; Morales C.Z.; Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis. Clin Vaccine Immunol 2010,17(2),298-303","journal-title":"Clin Vaccine Immunol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcla.20483","volume":"25","author":"Cheng Z.","year":"2011","unstructured":"Cheng Z.; Zhao J.W.; Sun Z.Q.; Evaluation of a novel fusion protein antigen for rapid serodiagnosis of tuberculosis. J Clin Lab Anal 2011,25(5),344-349","journal-title":"J Clin Lab Anal"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CVI.05553-11","volume":"19","author":"Dai J.","year":"2012","unstructured":"Dai J.; Jiang M.; Wang Y.; Qu L.; Gong R.; Si J.; Evaluation of a recombinant multiepitope peptide for serodiagnosis of Toxoplasma gondii infection. Clin Vaccine Immunol 2012,19(3),338-342","journal-title":"Clin Vaccine Immunol"},{"key":"ref=24","author":"de Souza M.Q.","year":"2013","unstructured":"de Souza M.Q.; Galdino A.S.; dos Santos J.C.; A recombinant multiepitope protein for hepatitis B diagnosis. BioMed Res Int 2013","journal-title":"BioMed Res Int"},{"key":"ref=25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003429","volume":"9","author":"Faria A.R.","year":"2015","unstructured":"Faria A.R.; de Castro Veloso L.; Coura-Vital W.; Novel recombinant multiepitope proteins for the diagnosis of asymptomatic Leishmania infantum-infected dogs. PLoS Negl Trop Dis 2015,9(1)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=26","volume":"2016","author":"Galdino A.S.","year":"2016","unstructured":"Galdino A.S.; Santos J.C.; Souza M.Q.; A novel structurally stable multiepitope protein for detection of HCV. Hepat Res Treat 2016,2016","journal-title":"Hepat Res Treat"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12934-017-0648-2","volume":"16","author":"Lee H.B.","year":"2017","unstructured":"Lee H.B.; Piao D.C.; Lee J.Y.; Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate. Microb Cell Fact 2017,16(1),33","journal-title":"Microb Cell Fact"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.26444\/aaem\/80699","volume":"24","author":"Schreterova E.","year":"2017","unstructured":"Schreterova E.; Bhide M.; Potocnakova L.; Borszekova Pulzova L.; Design, construction and evaluation of multi-epitope antigens for diagnosis of Lyme disease. Ann Agric Environ Med 2017,24(4),696-701","journal-title":"Ann Agric Environ Med"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"Kelley L.A.","year":"2015","unstructured":"Kelley L.A.; Mezulis S.; Yates C.M.; Wass M.N.; Sternberg M.J.; The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 2015,10(6),845-858","journal-title":"Nat Protoc"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/protein\/5.3.191","volume":"5","author":"B\u00f6hm G.","year":"1992","unstructured":"B\u00f6hm G.; Muhr R.; Jaenicke R.; Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng 1992,5(3),191-195","journal-title":"Protein Eng"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/JCM.30.10.2735-2739.1992","volume":"30","author":"Sundqvist V.A.","year":"1992","unstructured":"Sundqvist V.A.; Xu W.; Wahren B.; Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150. J Clin Microbiol 1992,30(10),2735-2739","journal-title":"J Clin Microbiol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/JCM.37.1.179-188.1999","volume":"37","author":"Greijer A.E.","year":"1999","unstructured":"Greijer A.E.; van de Crommert J.M.G.; Stevens S.J.C.; Middeldorp J.M.; Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol 1999,37(1),179-188","journal-title":"J Clin Microbiol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/JCM.38.4.1476-1481.2000","volume":"38","author":"Maine G.T.","year":"2000","unstructured":"Maine G.T.; Stricker R.; Schuler M.; Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol 2000,38(4),1476-1481","journal-title":"J Clin Microbiol"},{"key":"ref=34","first-page":"645","volume":"6","author":"Landini M.P.","year":"1990","unstructured":"Landini M.P.; Lazzarotto T.; Prenatal diagnosis of congenital cytomegalovirus infection: light and shade Herpes. J Virol 1990,6,645-649","journal-title":"J Virol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/JCM.33.10.2535-2542.1995","volume":"33","author":"Landini M.P.","year":"1995","unstructured":"Landini M.P.; Lazzarotto T.; Maine G.T.; Ripalti A.; Flanders R.; Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol 1995,33(10),2535-2542","journal-title":"J Clin Microbiol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/JCM.29.9.1868-1872.1991","volume":"29","author":"Landini M.P.","year":"1991","unstructured":"Landini M.P.; Ripalti A.; Sra K.; Pouletty P.; Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides. J Clin Microbiol 1991,29(9),1868-1872","journal-title":"J Clin Microbiol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12985-016-0604-5","volume":"13","author":"Marin L.J.","year":"2016","unstructured":"Marin L.J.; Santos de Carvalho Cardoso E.; Bispo Sousa S.M.; Prevalence and clinical aspects of CMV congenital Infection in a low-income population. Virol J 2016,13,148","journal-title":"Virol J"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","volume":"43","author":"Marsico C.","year":"2017","unstructured":"Marsico C.; Kimberlin D.W.; Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr 2017,43(1),38","journal-title":"Ital J Pediatr"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2013.12.010","volume":"22","author":"Lanzieri T.M.","year":"2014","unstructured":"Lanzieri T.M.; Dollard S.C.; Bialek S.R.; Grosse S.D.; Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis 2014,22,44-48","journal-title":"Int J Infect Dis"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.12688\/f1000research.10276.1","volume":"6","author":"Emery V.C.","year":"2017","unstructured":"Emery V.C.; Lazzarotto T.; Cytomegalovirus in pregnancy and the neonate. F1000 Res 2017,6,138","journal-title":"F1000 Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5694\/mja14.00183","volume":"201","author":"Lancini D.","year":"2014","unstructured":"Lancini D.; Faddy H.M.; Flower R.; Hogan C.; Cytomegalovirus disease in immunocompetent adults. Med J Aust 2014,201(10),578-580","journal-title":"Med J Aust"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/187152611797636703","volume":"11","author":"Ross S.A.","year":"2011","unstructured":"Ross S.A.; Novak Z.; Pati S.; Boppana S.B.; Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets 2011,11(5),466-474","journal-title":"Infect Disord Drug Targets"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cmi.2017.05.009","volume":"23","author":"Eguchi H.","year":"2017","unstructured":"Eguchi H.; Horita N.; Ushio R.; Diagnostic test accuracy of antigenaemia assay for PCR-proven cytomegalovirus infection-systematic review and meta-analysis. Clin Microbiol Infect 2017,23(12),907-915","journal-title":"Clin Microbiol Infect"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","volume":"364","author":"Boppana S.B.","year":"2011","unstructured":"Boppana S.B.; Ross S.A.; Shimamura M.; Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011,364(22),2111-2118","journal-title":"N Engl J Med"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.2010.423","volume":"303","author":"Boppana S.B.","year":"2010","unstructured":"Boppana S.B.; Ross S.A.; Novak Z.; Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010,303(14),1375-1382","journal-title":"JAMA"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jcla.1860060409","volume":"6","author":"Lazzarotto T.","year":"1992","unstructured":"Lazzarotto T.; Dalla Casa B.; Campisi B.; Landini M.P.; Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. J Clin Lab Anal 1992,6(4),216-218","journal-title":"J Clin Lab Anal"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1515\/CCLM.2001.014","volume":"39","author":"Genser B.","year":"2001","unstructured":"Genser B.; Truschnig-Wilders M.; St\u00fcnzner D.; Landini M.P.; Halwachs-Baumann G.; Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard. Clin Chem Lab Med 2001,39(1),62-70","journal-title":"Clin Chem Lab Med"},{"key":"ref=48","year":"2014","unstructured":"Olsen. Compositions and methods for the treatment and diagnosis of cytomegalovirus infection. JP5544309B2, 2014"},{"key":"ref=49","author":"Oldstone MBA","year":"1992","unstructured":"Oldstone MBA; Rice G; Diagnostic system for the detection of cytomegalovirus. EP0179152B1 1992"},{"key":"ref=50","author":"Horaud F","year":"1993","unstructured":"Horaud F; Michelson S; Barzu O; Boue A; Amadei C; Monoclonal antibodies to cytomegalovirus and methods for the diagnosis in vitro of infections by human cytomegaloviruses, using monoclonal antibodies which react with a cytomegalovirus-induced protein kinase. EP0165830B1 1993"},{"key":"ref=51","author":"Oldstone MBA","year":"1989","unstructured":"Oldstone MBA; Rice G; Diagnostic system for the detection of cytomegalovirus. US4818678A 1989"},{"key":"ref=52","author":"Diamond DJ","year":"2004","unstructured":"Diamond DJ; Diagnostic reagents for human cytomegalovirus and methods of use. US6733973B2 2004"},{"key":"ref=53","author":"Gregory TM","year":"2001","unstructured":"Gregory TM; Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody. US6177241B1 2001"},{"key":"ref=54","author":"Landini MP","year":"2000","unstructured":"Landini MP; Ripalti A; Gregory TM; Flanders RT; Recombinant mono and poly antigens to detect cytomegalovirus- specific IgM in human sera by enzyme immunoassay. US6074817A 2000"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/MMBR.00040-07","volume":"72","author":"Kalejta R.F.","year":"2008","unstructured":"Kalejta R.F.; Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev 2008,72(2),249-265","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10096-014-2109-8","volume":"33","author":"Berth M.","year":"2014","unstructured":"Berth M.; Grangeot-Keros L.; Heskia F.; Dugua J.M.; Vauloup-Fellous C.; Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays. Eur J Clin Microbiol Infect Dis 2014,33(9),1579-1584","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=57","first-page":"161","volume":"31","author":"Johnson W.C.","year":"1985","unstructured":"Johnson W.C.; Circular dichroism and its empirical application to biopolymers. Methods Biochem Anal 1985,31,161-163","journal-title":"Methods Biochem Anal"},{"key":"ref=58","first-page":"164","volume":"3","author":"Corr\u00eaa D.H.A.","year":"2009","unstructured":"Corr\u00eaa D.H.A.; Ramos C.H.I.; The use of circular dichroism spectroscopy to study protein folding, form and function. Afr J Biochem Res 2009,3,164-173","journal-title":"Afr J Biochem Res"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0076-6879(73)27030-1","volume":"27","author":"Adler A.J.","year":"1973","unstructured":"Adler A.J.; Green eld NJ, Fasman GD. Circular dichroism and optical rotatory dispersion of proteins and poly- peptides. Methods Enzymol 1973,27,675-735","journal-title":"Methods Enzymol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.1021\/bi00483a001","volume":"29","author":"Dill K.A.","year":"1990","unstructured":"Dill K.A.; Dominant forces in protein folding. Biochemistry 1990,29(31),7133-7155","journal-title":"Biochemistry"},{"key":"ref=61","first-page":"919","volume":"16","author":"Buonsenso D.","year":"2012","unstructured":"Buonsenso D.; Serranti D.; Gargiullo L.; Ceccarelli M.; Ranno O.; Valentini P.; Congenital cytomegalovirus infection: current strategies and future perspectives. Eur Rev Med Pharmacol Sci 2012,16(7),919-935","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00404-018-4703-y","volume":"297","author":"Chiaie L.D.","year":"2018","unstructured":"Chiaie L.D.; Neuberger P.; Vochem M.; Lihs A.; Karck U.; Enders M.; No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre. Arch Gynecol Obstet 2018,297(6),1389-1395","journal-title":"Arch Gynecol Obstet"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jogc.2018.03.013","volume":"40","author":"Minsart A.F.","year":"2018","unstructured":"Minsart A.F.; Smiljkovic M.; Renaud C.; Use of cytomegalovirus-specific hyperimmunoglobulins in pregnancy: a retrospective cohort. J Obstet Gynaecol Can 2018,40(11),1409-1416","journal-title":"J Obstet Gynaecol Can"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000487302","volume":"45","author":"Gabrielli L.","year":"2019","unstructured":"Gabrielli L.; Bonasoni M.P.; Foschini M.P.; Histological analysis of term placentas from hyperimmune globulin-treated and untreated mothers with primary cytomegalovirus infection. Fetal Diagn Ther 2019,45(2),111-117","journal-title":"Fetal Diagn Ther"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"e00586","DOI":"10.1128\/mSphere.00586-18","volume":"4","author":"Jackson J.W.","year":"2019","unstructured":"Jackson J.W.; Hancock T.J.; Dogra P.; Anticytomegalovirus peptides point to new insights for CMV entry mechanisms and the limitations of in vitro screenings. MSphere 2019,4(1),e00586-e18","journal-title":"MSphere"},{"key":"ref=66","first-page":"1","volume":"42","author":"Gerna G.","year":"2019","unstructured":"Gerna G.; Lilleri D.; Human cytomegalovirus (HCMV) infection\/re-infection: development of a protective HCMV vaccine. New Microbiol 2019,42(1),1-20","journal-title":"New Microbiol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jog.13889","volume":"45","author":"Tanimura K.","year":"2019","unstructured":"Tanimura K.; Yamada H.; Maternal and neonatal screening methods for congenital cytomegalovirus infection. J Obstet Gynaecol Res 2019,45(3),514-521","journal-title":"J Obstet Gynaecol Res"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/942937","volume":"2011","author":"Adler S.P.","year":"2011","unstructured":"Adler S.P.; Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011,2011,1-9","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/JCM.01868-16","volume":"55","author":"Saldan A.","year":"2017","unstructured":"Saldan A.; Forner G.; Mengoli C.; Gussetti N.; Pal\u00f9 G.; Abate D.; Testing for cytomegalovirus in pregnancy. J Clin Microbiol 2017,55(3),693-702","journal-title":"J Clin Microbiol"},{"key":"ref=70","author":"Ribeiro PAF","year":"2015","unstructured":"Ribeiro PAF; Dias DS; Nogueira LM; Torres FAG; Felipe MSS; Prote\u00edna multiepitopo recombinante, seu processo de obten\u00e7\u00e3o e suas aplica\u00e7\u00f5es relacionadas ao citomegalovirus. BR1020150075430 2015"}],"container-title":["Recent Patents on Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:43:10Z","timestamp":1610584990000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173501\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10,25]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872208313666190716093911","relation":{},"ISSN":["1872-2083"],"issn-type":[{"value":"1872-2083","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}